High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma.

[1]  W. Evans,et al.  Clinical evaluation of sequentially scheduled cisplatin and vm26 in neuroblastoma: Response and toxicity , 1981, Cancer.

[2]  M. Greaves,et al.  Monoclonal antibody to ganglioside gq discriminates between haemopoietic cells and infiltrating neuroblastoma tumour cells in bone marrow , 1981, International journal of cancer.

[3]  H. Prentice,et al.  Treatment of Ewing's sarcoma with high-dose melphalan and autologous bone marrow transplantation. , 1981, Cancer treatment reports.

[4]  R. Abrams,et al.  HÆMOPOIETIC RECOVERY IN EWING'S SARCOMA AFTER INTENSIVE COMBINATION THERAPY AND AUTOLOGOUS MARROW INFUSION , 1980, The Lancet.

[5]  D. Hedley,et al.  Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan. , 1979, British Journal of Cancer.

[6]  L. Helson.  Investigational chemotherapy of neuroblastoma. , 1979, The Journal of the Florida Medical Association.

[7]  C. Cozzutto,et al.  Peptichemio in advanced neuroblastoma. , 1978, Cancer treatment reports.

[8]  T. Mcelwain,et al.  ORAL NON-ABSORBED ANTIBIOTICS PREVENT INFECTION IN ACUTE NON-LYMPHOBLASTIC LEUKÆMIA , 1977, The Lancet.

[9]  G. Rivera,et al.  Epipodophyllotoxin VM-26 in the treatment of childhood neuroblastoma. , 1977, Cancer treatment reports.

[10]  A. Green,et al.  Total‐body sequential segmental irradiation and combination chemotherapy for children with disseminated neuroblastoma , 1976, Cancer.

[11]  D. Ganick,et al.  Attempted treatment of a child with metastatic neuroblastoma employing syngeneic marrow transplantation. , 1976, Transplantation.

[12]  G. Bonadonna,et al.  Response and survival of patients with metastatic neuroblastoma after combination chemotherapy with adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and vincristine (NSC-67574). , 1974, Cancer chemotherapy reports.

[13]  P. Neiman,et al.  High‐dose cyclophosphamide therapy for malignant disease. Toxicity, tumor response, and the effects of stored autologous marrow , 1972 .

[14]  A. Evans,et al.  A proposed staging for children with neuroblastoma. Children's cancer study group A , 1971, Cancer.

[15]  T. Haddy,et al.  L-sarcolysin (NSC-8806) therapy for children with metastatic neuroblastoma. , 1968, Cancer chemotherapy reports.

[16]  M. Sullivan,et al.  CYCLOPHOSPHAMIDE THERAPY IN CHILDHOOD NEUROBLASTOMA. , 1964, The New England journal of medicine.

[17]  S. Sternberg,et al.  Cyclophosphamide and urinary bladder toxicity. , 1961, Cancer research.

[18]  D. Hedley,et al.  High dose melphalan and non-cryopreserved autologous bone marrow treatment of malignant melanoma and neuroblastoma. , 1979, Experimental hematology.

[19]  I. Bernstein,et al.  Multiagent chemotherapy for children with metastatic neuroblastoma: a report from Childrens Cancer Study Group. , 1979, Medical and pediatric oncology.

[20]  R. Nuscher,et al.  Bone marrow transplantation. , 1977, The American journal of nursing.

[21]  J. Ziegler,et al.  Burkitt's lymphoma--a model for intensive chemotherapy. , 1977, Seminars in oncology.